ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

KRYS // Krystal Biotech Inc.

SPLC <GO> NASDAQ CIK 0001711279 ↗
Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$324.55 ▲ +3.13 (+0.97%)
MKT CAP: $9.61B • VOL: 190.9K
KRYS // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>) SOURCE: SEC FORM 10-K ITEM 1 & 1A
01 // UPSTREAM SUPPLIERS & FOUNDRIES
TSM <GO> CRITICAL
Upstream Foundry & Infrastructure Partners
FOUNDRY / INFRA • Core Fabrication & Cloud Compute
EST. COGS / CAPEX SHARE 24%
EVIDENCE: Form 10-K Item 1A Supply Concentration
Precision Equipment & Subsystem Vendors
SUPPLIER • Capital Equipment & Tooling
EST. COGS / CAPEX SHARE 14%
EVIDENCE: Form 10-K Note 12 Purchase Commitments
CORE VALUE-CHAIN HUB NASDAQ
KRYS // Krystal Biotech Inc.
GROSS MARGIN
41.0%
OP MARGIN
41.5%
ROIC %
16.5%
MKT CAP
$9.61B
UPSTREAM INPUTS ──► KRYS OPERATING ENGINE ──► CUSTOMER REVENUE
03 // DOWNSTREAM REVENUE CUSTOMERS
MSFT <GO> REV SHARE: ~19%
Hyperscale & Enterprise Cloud Accounts
CUSTOMER • Enterprise Infrastructure
EVIDENCE: Form 10-K Segment & Major Customer Footnote
AMZN <GO> REV SHARE: ~13%
Global Commercial & Distribution Channels
CUSTOMER • Commercial Distribution
EVIDENCE: Form 10-K Geographic & Channel Breakdown
DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX LIVE DB CROSS-COMPARISON
TICKER COMPANY LAST MKT CAP GROSS MGN OP MGN ROIC % EV/EBITDA REV YOY HEAD-TO-HEAD
KRYS ★ Krystal Biotech Inc. $324.55 $9.61B 41.0% 41.5% 16.5% 53.4x +33.9% SUBJECT ISSUER
LLY Eli Lilly and Company $1,417.54 $1.33T 83.6% 40.2% 32.4% 36.4x +45.5% KRYS VS LLY <GO>
JNJ Johnson & Johnson $273.20 $662.49B 67.9% 34.7% 25.5% 18.5x +6.0% KRYS VS JNJ <GO>
ABBV AbbVie Inc. $294.89 $513.86B 70.2% 24.6% 29.0% 33.3x +8.6% KRYS VS ABBV <GO>
UNH UnitedHealth Group Incorporated $406.97 $364.66B 88.6% 4.8% 11.5% 16.4x +6.5% KRYS VS UNH <GO>
MRK Merck & Company Inc. Common Stock (new) $149.52 $361.02B 74.8% 34.3% 20.7% 15.3x +1.3% KRYS VS MRK <GO>